Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $26.58 Analyst target: $28.57 Upside: 7.49%
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company is headquartered in Sunnyvale, California.
See the full interactive analysis & chart →Informational only — not investment advice.